Dopamine targets cycling B cells independent of receptors/transporter for oxidative attack: Implications for non-Hodgkin’s lymphoma

Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation

2004 • 1,855 citations

Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues

2005 • 1,003 citations

Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death.

1993 • 855 citations

Cell-permeable Peptide Antioxidants Targeted to Inner Mitochondrial Membrane inhibit Mitochondrial Swelling, Oxidative Cell Death, and Reperfusion Injury

2004 • 750 citations

Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis

1997 • 663 citations

Germinal center cells express bcl‐2 protein after activation by signals which prevent their entry into apoptosis

1991 • 446 citations

Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop.

1994 • 363 citations

The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action

1989 • 343 citations

Non-Hodgkin Lymphoma: Diagnosis and Treatment

2005 • 335 citations

The Multiplicity of Serotonin Receptors: Uselessly Diverse Molecules or an Embarrassment of Riches?

2000 • 332 citations

The Parkinsonism-inducing Drug 1-Methyl-4-phenylpyridinium Triggers Intracellular Dopamine Oxidation

2000 • 305 citations

B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation

2006 • 303 citations

A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells

2005 • 213 citations

The Encyclopedia of life sciences

2002 • 189 citations

Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells

2003 • 169 citations

Lymphocytes transport serotonin and dopamine: agony or ecstasy?

2003 • 137 citations

The cytotoxicity of dopamine may be an artefact of cell culture

2002 • 135 citations

Complexity of the bi-directional neuroimmune junction in the spleen

2004 • 128 citations

Catecholaminergic suppression of immunocompetent cells

1998 • 121 citations

Improved Outcome When B-Cell Lymphoma Is Treated with Combinations of Immunoliposomal Anticancer Drugs Targeted to Both the CD19 and CD20 Epitopes

2004 • 120 citations

Thioredoxin Peroxidase-1 (peroxiredoxin-1) Is Increased in Thioredoxin-1 Transfected Cells and Results in Enhanced Protection against Apoptosis Caused by Hydrogen Peroxide but Not by Other Agents Including Dexamethasone, Etoposide, and Doxorubicin

2001 • 118 citations

AIDS-related lymphoproliferative disease

2005 • 113 citations

Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: selective review and hypothesis.

1998 • 112 citations

Potentiation of cellular antioxidant capacity by Bcl-2: implications for its antiapoptotic function

2003 • 110 citations

Measurements of catecholamine‐mediated apoptosis of immunocompetent cells by capillary electrophoresis

1997 • 105 citations

Preferential Cell Death of CD8+ Effector Memory (CCR7−CD45RA−) T Cells by Hydrogen Peroxide-Induced Oxidative Stress

2005 • 97 citations

5-Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells: reversal by selective serotonin reuptake inhibitors

2002 • 94 citations

Close encounters of the monoamine kind: immune cells betray their nervous disposition

2005 • 84 citations

The serotonin transporter (SLC6A4) is present in B‐cell clones of diverse malignant origin: probing a potential antitumor target for psychotropics

2005 • 83 citations

The 2000 Burkitt lymphoma trial in Malawi

2004 • 79 citations

Primary CNS lymphoma.

1999 • 75 citations

Prevention of programmed cell death in burkitt lymphoma cell lines by bcl‐2‐dependent and ‐independent mechanisms

1992 • 71 citations

Thioredoxin prolongs survival of B-type chronic lymphocytic leukemia cells

2000 • 70 citations

Repression of apoptosis in human B-lymphoma cells by CD40-ligand and Bcl-2: relationship to the cell-cycle and role of the retinoblastoma protein.

1996 • 68 citations

Nuclear Factor‐κB is Involved in the Catecholaminergic Suppression of Immunocompetent Cells

2000 • 62 citations

Bcl-2 Does Not Protect Burkitt's Lymphoma Cells From Oxidant-Induced Cell Death

1997 • 60 citations

Evaluation of rat striatal l-dopa and DA concentration after intraperitoneal administration of l-dopa prodrugs in liposomal formulations

2004 • 49 citations

Advances in the delivery of treatments for Parkinson’s disease

2005 • 38 citations

Dopa inhibits induced proliferative activity of murine and human lymphocytes.

1992 • 37 citations

The extrafollicular-to-follicular transition of human B lymphocytes: induction of functional globotriaosylceramide (CD77) on high threshold occupancy of CD40

1999 • 34 citations

Pharmacological studies with several analogs of mazindol: Correlation between effects on dopamine uptake and various in vivo responses

1981 • 31 citations

Oxidation of Proteinaceous Cysteine Residues by Dopamine-Derived H2O2 in PC12 Cells

2002 • 28 citations

Brain Drug Delivery System Bearing Dopamine Hydrochloride for Effective Management of Parkinsonism

1998 • 26 citations

Establishment and Characterization of Acute B-Cell Lymphocytic Leukemia Cell Line Showing (8; 14) and (14; 18) Chromosome Translocation

1990 • 22 citations

Evolving role of rituximab in the treatment of patients with non-Hodgkin's lymphoma

2005 • 22 citations

Increased Dopamine Content in Lymphocytes from High-Dose <i>L</i>-Dopa-Treated Parkinson’s Disease Patients

2005 • 19 citations

Burkitt lymphoma in Papua New Guinea—40 years on

2005 • 14 citations

Nuclear factor-kB is involved in the catecholaminergic suppression of immunocompetent cells

2000 • 9 citations

Neuroimmunomodulation

2004 • 5 citations